留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

如何根据临床指南进行个体化治疗——从脓毒症与感染性休克治疗国际指南说起

赵华 刘大为

赵华, 刘大为. 如何根据临床指南进行个体化治疗——从脓毒症与感染性休克治疗国际指南说起[J]. 协和医学杂志, 2022, 13(2): 174-179. doi: 10.12290/xhyxzz.2021-0811
引用本文: 赵华, 刘大为. 如何根据临床指南进行个体化治疗——从脓毒症与感染性休克治疗国际指南说起[J]. 协和医学杂志, 2022, 13(2): 174-179. doi: 10.12290/xhyxzz.2021-0811
ZHAO Hua, LIU Dawei. How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 174-179. doi: 10.12290/xhyxzz.2021-0811
Citation: ZHAO Hua, LIU Dawei. How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 174-179. doi: 10.12290/xhyxzz.2021-0811

如何根据临床指南进行个体化治疗——从脓毒症与感染性休克治疗国际指南说起

doi: 10.12290/xhyxzz.2021-0811
基金项目: 

北京市科技计划项目:器官血流动力学导向的sepsis复苏策略建立和示范化应用 Z201100005520038

详细信息
    通讯作者:

    刘大为,E-mail:dwliu@163.com

  • 中图分类号: R631+4

How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock

Funds: 

Beijing Science and Technology Project: Establishment and Application of Organ Hemodynamically Guided Sepsis Resuscitation Strategy Project Z201100005520038

More Information
  • 摘要: 脓毒症一直是全球死亡的主要原因。基于循证医学证据的脓毒症治疗指南推动了全球对脓毒症的认知,持续强化了医务人员对脓毒症发生发展的理解,不断规范临床治疗,为临床医疗行为标准的建立提供了依据,是“个体化”治疗实施的前提。当面对患者个体时,指南推荐意见不能完全代替临床医生的决策能力,所有诊疗决策需根据患者自身的病理生理特点进行定量干预。本文通过对2021年版《拯救脓毒症运动:脓毒症与感染性休克治疗国际指南》推荐意见进行分析,浅谈“个体化”治疗与指南之间的相关性,如何在临床干预中坚持“目标与目的”“连续与动态”“治疗与再损伤”三大原则,如何根据指南进行“个体化”治疗。
    作者贡献:赵华负责文献分析和论文撰写;刘大为负责论文构思及设计,指导论文撰写与修订。
    利益冲突:所有作者均声明不存在利益冲突
  • [1] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis compaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49: e1063-e1143.
    [2] Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock[J]. N Engl J Med, 2014, 370: 1583-1593. doi:  10.1056/NEJMoa1312173
    [3] Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial[J]. JAMA, 2020, 323: 938-949. doi:  10.1001/jama.2020.0930
    [4] Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial[J]. JAMA, 2019, 321: 654-664. doi:  10.1001/jama.2019.0071
    [5] Zampieri FG, Damiani LP, Bakker J, et al. Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock, A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial[J]. Am J Respir Crit Care Med, 2020, 201: 423-429. doi:  10.1164/rccm.201905-0968OC
    [6] Liu R, Greenstein JL, Granite SJ, et al. Data-driven discovery of a novel sepsis preshock state predicts impending septic shock in the ICU[J]. Sci Rep, 2019, 9: 6145. doi:  10.1038/s41598-019-42637-5
    [7] De Backer D, Orbegozo Cortes D, Donadello K, et al. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock[J]. Virulence, 2014, 5: 73-79. doi:  10.4161/viru.26482
    [8] 刘大为, 王小亭, 张宏民, 等. 重症血流动力学治疗——北京共识[J]. 中华内科杂志, 2015, 54: 248-271. doi:  10.3760/cma.j.issn.0578-1426.2015.03.021
    [9] Beaubien-Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system[J]. Ultrasound J, 2020, 12: 16. doi:  10.1186/s13089-020-00163-w
    [10] De-Lima-Oliveira M, Salinet ASM, Nogueira RC, et al. Intracranial Hypertension and Cerebral Autoregulation: A systematic review and meta-analysis[J]. World Neurosurg, 2018, 113: 110-124. doi:  10.1016/j.wneu.2018.01.194
    [11] Sheridan DC, Cloutier R, Kibler A, et al. Cutting-Edge technology for rapid beside assessment of capillary refill time for early diagnosis and resuscitation of sepsis[J]. Front Med (Lausanne), 2020, 7: 612303.
    [12] Geri G, Vignon P, Aubry A, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a posthoc analysis[J]. Intensive Care Med, 2019, 45: 657-667. doi:  10.1007/s00134-019-05596-z
    [13] Du W, Liu D, Long Y, et al. The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia[J]. Crit Care Med, 2017, 45: e1247-e1253. doi:  10.1097/CCM.0000000000002721
    [14] Lat I, Coopersmith CM, De Backer D, et al. The surviv-ing sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients[J]. Intensive Care Med Exp, 2021, 9: 10. doi:  10.1186/s40635-021-00369-9
    [15] Khanna A, English SW, Wang XS, et al. Angiotensin Ⅱ for the Treatment of Vasodilatory Shock[J]. N Engl J Med, 2017, 377: 419-430. doi:  10.1056/NEJMoa1704154
    [16] Porizka M, Kopecky P, Dvorakova H, et al. Methylene blue administration in patients with refractory distributive shock-a retrospective study[J]. Sci Rep, 2020, 10: 1828. doi:  10.1038/s41598-020-58828-4
    [17] Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358: 877-887. doi:  10.1056/NEJMoa067373
    [18] Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial[J]. JAMA, 2016, 316: 509-518. doi:  10.1001/jama.2016.10485
    [19] Nagendran M, Russell JA, Walley KR, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials[J]. Intensive Care Med, 2019, 45: 844-855. doi:  10.1007/s00134-019-05620-2
    [20] Liu ZM, Chen J, Kou Q, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial[J]. Intensive Care Med, 2018, 44: 1816-1825. doi:  10.1007/s00134-018-5267-9
  • 加载中
计量
  • 文章访问数:  101
  • HTML全文浏览量:  6
  • PDF下载量:  69
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-12-31
  • 录用日期:  2022-01-17
  • 网络出版日期:  2022-01-17
  • 刊出日期:  2022-03-30

目录

    /

    返回文章
    返回